French Regulator Shutters Vaccine Manufacturer Over GMP Deficiencies

Drug GMP Report
A A
France’s National Agency for Medicines and Health Products Safety has ordered French vaccine maker Theravectys to halt production at its Villejuif plant for seven months after apparently finding numerous GMP deficiencies.

To View This Article:

Login

Subscribe To Drug GMP Report